These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 28151751)
1. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum. Royston C; Bardhan KD Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751 [TBL] [Abstract][Full Text] [Related]
2. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital. Royston C; Caygill C; Charlett A; Bardhan KD Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366 [TBL] [Abstract][Full Text] [Related]
3. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study. Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and prevention of oesophageal adenocarcinoma. Ness-Jensen E Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549 [TBL] [Abstract][Full Text] [Related]
6. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis. Eusebi LH; Cirota GG; Zagari RM; Ford AC Gut; 2021 Mar; 70(3):456-463. PubMed ID: 32732370 [TBL] [Abstract][Full Text] [Related]
7. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study. Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776 [TBL] [Abstract][Full Text] [Related]
8. The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off. Masclee GM; Coloma PM; de Wilde M; Kuipers EJ; Sturkenboom MC Aliment Pharmacol Ther; 2014 Jun; 39(11):1321-30. PubMed ID: 24738722 [TBL] [Abstract][Full Text] [Related]
9. Influence of age and sex on endoscopic findings of gastrooesophageal reflux disease: an endoscopy database study. Menon S; Jayasena H; Nightingale P; Trudgill NJ Eur J Gastroenterol Hepatol; 2011 May; 23(5):389-95. PubMed ID: 21448069 [TBL] [Abstract][Full Text] [Related]
10. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170 [TBL] [Abstract][Full Text] [Related]
11. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568 [TBL] [Abstract][Full Text] [Related]
12. Psychosocial factors and their association with reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma. Denver P; Donnelly M; Murray LJ; Anderson LA World J Gastroenterol; 2013 Mar; 19(11):1770-7. PubMed ID: 23555165 [TBL] [Abstract][Full Text] [Related]
13. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420 [TBL] [Abstract][Full Text] [Related]
14. Gender difference in gastro-esophageal reflux diseases. Asanuma K; Iijima K; Shimosegawa T World J Gastroenterol; 2016 Feb; 22(5):1800-10. PubMed ID: 26855539 [TBL] [Abstract][Full Text] [Related]
15. Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link? Caygill CP; Royston C; Charlett A; Wall CM; Gatenby PA; Ramus JR; Watson A; Winslet M; Hourigan CS; Dev Bardhan K Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):801-6. PubMed ID: 21701391 [TBL] [Abstract][Full Text] [Related]
16. GORD and Barrett's oesophagus after bariatric procedures: multicentre prospective study. Genco A; Castagneto-Gissey L; Gualtieri L; Lucchese M; Leuratti L; Soricelli E; Casella G Br J Surg; 2021 Dec; 108(12):1498-1505. PubMed ID: 34738106 [TBL] [Abstract][Full Text] [Related]
17. The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma. den Hoed CM; van Blankenstein M; Dees J; Kuipers EJ Br J Cancer; 2011 Jul; 105(2):200-5. PubMed ID: 21673678 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Frazzoni M; Manno M; De Micheli E; Savarino V Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016 [TBL] [Abstract][Full Text] [Related]
19. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study. Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG; Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986 [TBL] [Abstract][Full Text] [Related]
20. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study. Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]